570 related articles for article (PubMed ID: 21891916)
21. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
22. Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation.
Wu HT; Ko SY; Fong JH; Chang KW; Liu TY; Kao SY
J Oral Pathol Med; 2009 Feb; 38(2):206-13. PubMed ID: 18331557
[TBL] [Abstract][Full Text] [Related]
23. [Study and detection of telomerase activity in oral squamous cell carcinomas and precancerous lesions].
Yao H; Wu B; Wu Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Nov; 34(6):328-30. PubMed ID: 11776870
[TBL] [Abstract][Full Text] [Related]
24. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Kannan S; Tahara H; Yokozaki H; Mathew B; Nalinakumari KR; Nair MK; Tahara E
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):413-20. PubMed ID: 9184774
[TBL] [Abstract][Full Text] [Related]
26. Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study.
Thubashini M; Malathi N; Kannan L
Indian J Dent Res; 2011; 22(2):256-9. PubMed ID: 21891896
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
28. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study.
Varghese SS; Sunil PM; Madhavan RN
Cancer Biomark; 2010-2011; 8(3):155-60. PubMed ID: 22012771
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
30. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
31. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902
[TBL] [Abstract][Full Text] [Related]
32. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis.
Chang LY; Lin SC; Chang CS; Wong YK; Hu YC; Chang KW
J Oral Pathol Med; 1999 Oct; 28(9):389-96. PubMed ID: 10535361
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
35. Cytomorphometric analysis of oral submucous fibrosis and leukoplakia using methyl green-pyronin Y, Feulgen staining and exfoliative brush cytology.
Metgud R; Gupta K; Prasad U; Gupta J
Biotech Histochem; 2015 Jan; 90(1):8-13. PubMed ID: 24867495
[TBL] [Abstract][Full Text] [Related]
36. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evaluation of expression of cytokeratin 19 in different histological grades of leukoplakia and oral squamous cell carcinoma.
Ram Prassad VV; Nirmala NR; Kotian MS
Indian J Dent Res; 2005; 16(1):6-11. PubMed ID: 16375229
[TBL] [Abstract][Full Text] [Related]
38. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
39. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
40. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
